21=severe itching every day of the week). In addition, treatment with dupilumab resulted in a 15.86-point reduction in urticaria activity (itch and hive) severity from baseline versus an 11.21 ...
to treat adults and pediatric patients aged 12 years and older with chronic spontaneous urticaria (CSU) whose disease is not adequately controlled with H1 antihistamine treatment. The target ...